August 08, 2013
Pfizer Inc. unit Wyeth Pharmaceuticals Inc. will pay $13.5 million in attorneys' fees for a drug-related class action settlement after a New York federal judge on Wednesday ruled that the stockholder who objected to the payout lacked standing.
November 13, 2012
Pfizer Inc. unit Wyeth Pharmaceuticals Inc. agreed Friday to pay $67.5 million to settle a class action in New York federal court brought by a group of investors who say the company failed to disclose serious side effects associated with the antidepressant Pristiq.
September 18, 2012
A New York federal judge on Tuesday granted class certification to a group of investors accusing Pfizer Inc. unit Wyeth Pharmaceuticals Inc. of failing to disclose serious side effects associated with the antidepressant Pristiq.
May 10, 2012
A New York federal judge on Thursday said he will likely grant class certification to a group of investors who claim Pfizer Inc. unit Wyeth Pharmaceuticals Inc. did not disclose serious side effects associated with the antidepressant Pristiq.
October 21, 2011
A Massachusetts pension fund asked a New York federal court Friday to certify a class of investors who claim that Pfizer Inc. unit Wyeth Pharmaceuticals Inc. obscured possibly serious side effects of its menopause and depression drug Pristiq in public announcements.